Polypill holds promise for people with chronic disease

Polypill holds promise for people with chronic disease

Bibliographic Details
Main Author:	Jacqui Wise
Format:	Article
Language:	English
Published:	The World Health Organization 2005-12-01
Series:	Bulletin of the World Health Organization
Online Access:	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862005001200005

Similar Items

Polypill for cardiovascular disease prevention.
by: Dalton, A
Published: (2013)

The Concept of the Polypill in the Prevention of Cardiovascular Disease
by: Brandon Wiley, et al.
Published: (2014-04-01)

Medicinal herbs: Potential polypills in cardiovascular diseases
by: Samaneh Noroozi, et al.
Published: (2021-04-01)

The polypill: the solution for prevention of coronary heart disease?
by: Hendarto Natadidjaja
Published: (2016-02-01)

Polypill revisited – Unity in diversity
by: Gheorghe-Andrei Dan, et al.
Published: (2020-08-01)

Polypill" conception in modern cardiology
by: I E Chazova, et al.
Published: (2018-12-01)

Polypills with or without aspirin for primary prevention of cardiovascular disease
by: Mant, J, et al.
Published: (2021)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
by: Apichard Sukonthasarn, et al.
Published: (2021-03-01)

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
by: J. Masjuan, et al.
Published: (2021-01-01)

Three-dimensional printing of flexible polypill
by: Yasir Karkar, et al.
Published: (2023-12-01)

The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]
by: Lopez-Jaramillo P, et al.
Published: (2023-10-01)

Has the polypill finally proven its worth?
by: Treadwell, J
Published: (2019)

Exercise Rehabilitation in Heart Disease: the real “polypill” for primary and secondary prevention
by: Massimo F. Piepoli
Published: (2005-06-01)

Preventing the progression of climate change: one drug or polypill?
by: Hugh Montgomery
Published: (2017-03-01)

Redefining the polypill: pros and cons in cardiovascular precision medicine
by: Siddharth Birla, et al.
Published: (2023-09-01)

Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk
by: Usherwood Tim, et al.
Published: (2010-08-01)

Polypill Therapy for Cardiovascular Disease Prevention and Combination Medication Therapy for Hypertension Management
by: Keisuke Narita, et al.
Published: (2023-11-01)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
by: Omneya A. Kandil, et al.
Published: (2022-04-01)

Polypill therapy and frailty in elderly: Time to stop treating everything
by: Sunil Kumar, et al.
Published: (2021-04-01)

The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.
by: C Raina Elley, et al.
Published: (2012-01-01)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
by: Hae Won Jung, et al.
Published: (2023-09-01)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
by: Lopez-Lopez JP, et al.
Published: (2023-09-01)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
by: Gunaratne Padma S, et al.
Published: (2011-01-01)

Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens
by: Karavasili, Christina, et al.
Published: (2024)

Polypill eligibility and equivalent intake in a Swiss population-based study
by: Julien Castioni, et al.
Published: (2021-03-01)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
by: Lilian Grigorian-Shamagian, et al.
Published: (2021-08-01)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
by: Jowett, S, et al.
Published: (2017)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.
by: Sue Jowett, et al.
Published: (2017-01-01)

An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.
by: PILL Collaborative Group, et al.
Published: (2011-01-01)

Rapid Ebola tests hold promise
Published: (2015-04-01)

Ginseng Holds Promise Against Obesity
by: Rabia Rehan, et al.
Published: (2021-09-01)

Polypill Brings Benefits to Patients with Cardiovascular Disease, Both Improving Medication Adherence and Demonstrating the Concept of Chronotherapy [Letter]
by: Zhu LL, et al.
Published: (2023-09-01)

Sclerostin Modulation Holds Promise for Dental Indications
by: Mohamed G. Hassan, et al.
Published: (2018-11-01)

Pancreatic Cancer: Targeted Therapy Holds the Promise
by: Zhijun Zhou, et al.
Published: (2022-01-01)

Simple, Accurate and Multianalyte Determination of Thirteen Active Pharmaceutical Ingredients in Polypills by HPLC-DAD
by: Barbara Żuromska-Witek, et al.
Published: (2022-12-01)

Evaluation of the polypill therapy effectiveness in patients with arterial hypertension and dyslipidemia who underwent COVID-19
by: V.E. Oleynikov, et al.
Published: (2024-03-01)

Development of pH-Responsive Polypills via Semi-Solid Extrusion 3D Printing
by: Fan Wang, et al.
Published: (2023-03-01)

Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review
by: Ana Baumgartner, et al.
Published: (2020-02-01)

Green and efficient determination of ʟ-dopa in complex polypill formulations using a magnetic microplate
by: Hweiyan Tsai, et al.
Published: (2018-10-01)

3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy
by: Hellen Windolf, et al.
Published: (2022-04-01)